Yield Growth Clears Final Hurdle to Market Six New Products in Oregon
June 20th, 2019
App, Exclusive, News, Top Story
The cannabis industry is projected to reach $66.3 billion by 2025, according to Grand View Research, representing a blistering 23.9% compound annual growth rate. While medical and adult-use cannabis capture the headlines, cannabinoid-infused topicals, tinctures and capsules could become some of the fastest growing subsets of the market. Investors may want to take a closer look at this potentially-lucrative corner of the market.
The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (Frankfurt: YG3), a health and wellness focused developer of cannabis products, recently secured final packaging approvals from the Oregon Liquor Control Commission (OLCC) for six new THC- and CBD-infused topicals and tinctures to be marketed under the Wright & Well brand.
Let’s take a look at the rise of cannabis topicals and tinctures and why the OLCC’s approval of six new products could be a transformative event for Yield Growth and its shareholders.
The Rise of Topicals & Tinctures
There are a growing number of cannabis consumption methods and each has its own set of benefits and drawbacks. For instance, cannabis topicals are reshaping the accessibility, safety, and efficacy of cannabinoid consumption and opening the market to consumers that wouldn’t otherwise realize the benefits of cannabis. Tinctures similarly provide an easier and more convenient way to consume cannabinoids without smoking, edibles or beverages.
Topicals have become popular for localized pain relief, muscle soreness, tension and inflammation, but emerging science shows potential benefits for psoriasis, dermatitis, itching, headaches, and cramps. They’re a go-to solution for many consumers that want to experience less pain following an intense workout or attempt to reduce their use of prescription pharmaceuticals to treat arthritis pain.
Tinctures are alcohol-based extracts that were the primary form of cannabis medicine in the United States until cannabis prohibition. The combination of easy self-titration and a long shelf life makes tinctures one of the most convenient ways to consume cannabis. Consumers don’t have to worry about product going bad — as is the case with many edibles and beverages — or having to smoke cannabis to realize the benefits.
Six New Products Approved in Oregon
Yield Growth recently secured final packaging approval from the Oregon Liquor Control Commission, or OLCC, for six new THC- and CBD-infused topicals and tinctures to be marketed under the Wright & Well brand. With the approval in place, the company will begin distributing the products through Nova Paths — an Oregon-based cannabis licensed distributor with relationships with over 400 licensed cannabis retail stores.
“The OLCC packaging approval is one of the most rigorous processes to complete before products can be legally manufactured and sold in Oregon,” said Yield Growth CEO Penny Green in a recent press release announcing the approvals. “Now that we have successfully completed the process, we have cleared the final hurdle, and we expect manufacturing to be complete in early July, and sales to begin at the end of July.”
The company’s six products include:
- Be Chill Tincture (THC: Purple Hindu Kush, CBD: hemp source)
- Be Better CBD Tincture (CBD: hemp source)
- Be Better CBD Extra Strength Tincture (CBD: hemp source)
- Be Relieved Pain Gel (THC: Purple Hindu Kush, CBD: hemp source)
- Be Free Pain Balm (THC: Purple Hindu Kush, CBD: hemp source)
- Be Loved Massage Oil (THC: Purple Hindu Kush, CBD: hemp source)
The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (Frankfurt: YG3) is well positioned to capitalize on rising demand for THC- and CBD-infused topicals and tinctures in Oregon’s burgeoning market. With sales expected in July, investors may want to take a closer look at the company as it moves further out of its development stage and into its commercialization stage in the massive cannabis wellness subsector.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Media Group (CannabisFN), owned and operated by CFN Enterprises Inc. (OTCQB: CNFN), is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.